These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 7631443)

  • 1. [Postulosis palmoplantaris caused by angiotensin-converting enzyme inhibitors].
    Eriksen JG; Christiansen JJ; Asmussen I
    Ugeskr Laeger; 1995 Jun; 157(23):3335-6. PubMed ID: 7631443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Initial manifestation of eruptive exanthematous psoriasis vulgaris caused by captopril medication].
    Hauschild TT; Bauer R; Kreysel HW
    Hautarzt; 1986 May; 37(5):274-7. PubMed ID: 3525465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinctive properties of perindopril among converting enzyme inhibitors in congestive heart failure.
    Sami MH
    Can J Cardiol; 1994 Nov; 10 Suppl D():13D-16D. PubMed ID: 7954033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Possible participation of angiotensin-converting enzyme and leukocyte elastase in the pathogenesis of insulin-independent diabetes mellitus].
    Dotsenko VL; Demidova TIu; Neshkova EA; Ametov AS; Iarovaia GA
    Vopr Med Khim; 1998; 44(2):203-12. PubMed ID: 9634724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ACE inhibitors and cough.
    Yeşil S; Yeşil M; Bayata S; Postaci N
    Angiology; 1994 Sep; 45(9):805-8. PubMed ID: 8092546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative haemodynamic responses to the first dose of short- and long-acting ACE inhibitors in patients with congestive heart failure.
    Anthopoulos L; Apostolou T; Bonoris P; Foussas S; Lefkos N; Zombolos S
    Curr Med Res Opin; 2001; 17(4):290-7. PubMed ID: 11922403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin-converting enzyme inhibitors and psoriasis.
    Coulter DM; Pillans PI
    N Z Med J; 1993 Sep; 106(963):392-3. PubMed ID: 8396227
    [No Abstract]   [Full Text] [Related]  

  • 9. Interaction between neutral endopeptidase and angiotensin converting enzyme inhibition in rats with myocardial infarction: effects on cardiac hypertrophy and angiotensin and bradykinin peptide levels.
    Duncan AM; James GM; Anastasopoulos F; Kladis A; Briscoe TA; Campbell DJ
    J Pharmacol Exp Ther; 1999 Apr; 289(1):295-303. PubMed ID: 10087017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is there a role for bradykinin in the therapeutic and side effects of angiotensin-converting enzyme inhibitors?
    Marceau F
    Can J Cardiol; 1997 Feb; 13(2):187-94. PubMed ID: 9070170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of choroidal neovascularization by inhibiting angiotensin-converting enzyme: minimal role of bradykinin.
    Nagai N; Oike Y; Izumi-Nagai K; Koto T; Satofuka S; Shinoda H; Noda K; Ozawa Y; Inoue M; Tsubota K; Ishida S
    Invest Ophthalmol Vis Sci; 2007 May; 48(5):2321-6. PubMed ID: 17460297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-converting enzyme inhibition by perindopril in the treatment of cardiovascular disease.
    Brugts JJ; Ferrari R; Simoons ML
    Expert Rev Cardiovasc Ther; 2009 Apr; 7(4):345-60. PubMed ID: 19379059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First-dose response to angiotensin-converting enzyme inhibition in congestive cardiac failure: a Malaysian experience.
    Navookarasu NT; Rahman AR; Abdullah I
    Int J Clin Pract; 1999; 53(1):25-30. PubMed ID: 10344062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Psychotropic effects of angiotensin-converting enzyme inhibitors: what are the arguments?].
    Mesure G; Fallet A; Chevalier JF
    Encephale; 1995; 21(5):609-14. PubMed ID: 8529571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should the use of short acting angiotensin-converting enzyme inhibitors be abandoned?
    Erman A; Boner G; van Dijk DJ
    J Renin Angiotensin Aldosterone Syst; 2000 Dec; 1(4):365-8. PubMed ID: 11967825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Kinins: their nature and their potential role in the cardiovascular effects of angiotensin-converting enzyme inhibitors].
    Adam A; Blais C; Loute G
    Nephrologie; 2000; 21(4):163-72. PubMed ID: 10976431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The blood vessel as a target organ in hypertension: protective effect of perindopril.
    Plante GE
    Can J Cardiol; 1994 Nov; 10 Suppl D():25D-29D. PubMed ID: 7954036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors.
    Linz W; Wiemer G; Gohlke P; Unger T; Schölkens BA
    Pharmacol Rev; 1995 Mar; 47(1):25-49. PubMed ID: 7784479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of ACE inhibition on myocardial damage, the Kallikrein-Kinin system and hemostasis during cardiopulmonary bypass surgery.
    Walter T; Helber U; Bail D; Heller W; Hoffmeister HM
    Thorac Cardiovasc Surg; 2002 Jun; 50(3):150-4. PubMed ID: 12077687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intervention in the renin-angiotensin and kallikrein-kinin systems. Pharmacologic basis of the action of ACE inhibitors].
    Linz W; Busch AE
    Pharm Unserer Zeit; 2003; 32(1):18-22. PubMed ID: 12577756
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.